Armin Lahm

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Cancer Vaccines. Top assignees: Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, Nouscom Ag, Glaxosmithkline Biologicals Sa. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Armin Lahm. Retrieved from https://idiyas.com/inventor/armin-lahm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 3)

% Patents Active = 73.7

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 75(Granted Patents)

Location History:

Rome, IT (1998 - 2023)
Rom, IT (2021 - 2023)

Company Filing History:

6 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

Glaxosmithkline Biologicals Sa

patents

4. 2 out of 2

Istituto Di Ricerche Di Biologica Molecolare P. Angeletti S.p.a.

patents

5. 2 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Personalized Cancer Vaccine

Epstein-Barr Virus

Monoclonal Antibody

Tumor Neoantigens

Hepatitis C Vaccine

Interleukin-6 Receptor

Co-Agonists

Non Human Great Apes

Cancer Mutations

Adenovirus Vectors

Nucleic Acid Sequences

Mimotopes

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12749556 - SELECTION OF CANCER MUTATIONS FOR GENERATION OF A PERSONALIZED CANCER VACCINE (2026-09-29),

2. 12576143 - TELEOST INVARIANT CHAIN CANCER VACCINE (2026-03-17),

3. 12264179 - Epstein-Barr Virus antigen constructs (2025-04-01),

4. 11773139 - Epstein-barr virus antigen constructs (2023-10-03),

5. 11643467 - Monoclonal antibody anti-FGFR4 (2023-05-09),

6. 11578109 - Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers (2023-02-14),

7. 11098324 - Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof (2021-08-24),

8. 10745696 - HC-CDR3-only libraries with reduced combinatorial redundancy and optimized loop length distribution (2020-08-18),

9. 10493125 - Co-agonists of the glucagon and GLP-1 receptors (2019-12-03),

10. 9056090 - Hepatitis C virus nucleic acid vaccine (2015-06-16),

11. 8142794 - Hepatitis C virus vaccine (2012-03-27),

12. 7598362 - Hepatitis C virus vaccine (2009-10-06),

13. 7282365 - Rhesus HER2/neu, nucleotides encoding same, and uses thereof (2007-10-16),

14. 7078215 - HCV NS2/3 fragments and uses thereof (2006-07-18),

15. 7034108 - Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof (2006-04-25),

Title: The Innovative Mind of Armin Lahm

Introduction: Armin Lahm, a visionary inventor based in Rome, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Armin Lahm holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Armin Lahm has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized various industries. His passion for pushing the boundaries of technology has led to numerous successful inventions that have garnered international acclaim.

Collaborations: Throughout his career, Armin Lahm has collaborated with top engineers, scientists, and designers from around the globe, fostering a culture of innovation and creativity. His ability to work seamlessly in multidisciplinary teams has been instrumental in bringing his ideas to life.

Conclusion: Armin Lahm's relentless pursuit of innovation and his unwavering dedication to creating a better future through technology make him a true pioneer in the world of inventions. His impact on the industry is profound, and his legacy will continue to inspire generations of inventors to come.

Profile summary based on public USPTO records.